Press Releases

Press releases are archived according to their release date. For press releases by topic, please see the Issue Positions page.

“Prescription drug abuse is a big problem in Utah. A recent study found that our state ranks fifth in the nation in drug overdose deaths. That’s why I’m so glad Congress has passed the Ensuring Patient Access and Effective Drug Enforcement Act.”  

Washington, D.C.— Yesterday the House of Representatives passed legislation that will help ensure that prescription drugs get to the patients who need them and are not abused for improper purposes. Senator Orrin Hatch, R-Utah, the President Pro Tempore of the United States Senate, and sponsor of the bipartisan Ensuring Patient Access and Effective Drug Enforcement Act, applauded the move.

/Users/mw43095/Desktop/Video Screenshots/Screen Shot 2015-09-28 at 4.png

(Via YouTube) 

Prescription drug abuse is a big problem in Utah. A recent study found that our state ranks fifth in the nation in drug overdose deaths. That’s why I’m so glad Congress has passed the Ensuring Patient Access and Effective Drug Enforcement Act to encourage greater collaboration between law enforcement and the private sector in fighting prescription drug abuse.  This bill will motivate drug manufacturers, distributors, and pharmacies to step up efforts to prevent diversion of drugs for improper purposes.  At the same time, it will put in place safeguards to ensure that patients who truly need medications are able to get them. I’m looking forward to the President signing this important bill into law.

Currently, the Controlled Substances Act (CSA) does not make clear which factors the Drug Enforcement Agency (DEA) should consider when reviewing an application to manufacture or distribute prescription drugs.  Hatch’s legislation directs the DEA to use findings that Congress compiled while drafting the CSA to define those factors.  The bill also defines the circumstances under which the Attorney General can suspend a company’s registration without a court proceeding.  Finally, it allows companies that violate the CSA an opportunity to work with the DEA to correct the violation before having their registration revoked. 

A summary of the bill’s key provisions can be found here.